Our eShop is currently on maintenance and therefore only available with limited functionality. Quoting is possible. Purchasing is not possible. The entire functionality will be available again from May 5th 2025, 00:01 CEST. Thanks for your understanding.

Non-Viral Delivery Solutions

Tech Support
Non-Viral Delivery Solutions
 

RNA/DNA in vivo delivery is the most powerful alternative to viral vectors for nucleic acid-based therapies. They bring reliability, safety and costs.

Availability: 
See more Products below
*Custom/bulk order quotes are provided within 72 hours of request.
Non-Viral Delivery Solutions
Non-Viral Delivery Solutions

RNA/DNA in vivo delivery is the most powerful alternative to viral vectors for nucleic acid-based therapies. They bring reliability, safety and costs.

Item No.:
Non_viral_in_vivo_delivery
Availability:

Overview

Specifications

Choose your product

Products (8)

  • LipidBrick® for LNP formulation
    Documents
    LipidBrick® for LNP formulation
    Item no.
    101000232
    Amount of Reagent
    LipidBrick® IM21.7c 50 mg
    Item no.
    101000232
    Amount of Reagent
    LipidBrick® IM21.7c 50 mg
    Item no.
    101000172
    Amount of Reagent
    LipidBrick® IM21.7c 250 mg
    Item no.
    101000173
    Amount of Reagent
    LipidBrick® IM21.7c 1 g
  • in vivo-jetPEI®
    Documents
    in vivo-jetPEI®
    Item no.
    101000040
    Amount of Reagent
    in vivo-jetPEI® 0.1 mL
    Item no.
    101000040
    Amount of Reagent
    in vivo-jetPEI® 0.1 mL
    Item no.
    101000030
    Amount of Reagent
    in vivo-jetPEI® 0.5 mL
    Item no.
    102000003
    Amount of Reagent
    in vivo-jetPEI® GMP powder 10 g
  • in vivo-jetRNA®+
    Documents
    in vivo-jetRNA®+
    Item no.
    101000122
    Amount of Reagent
    in vivo-jetRNA®+ 1 mL
    Item no.
    101000122
    Amount of Reagent
    in vivo-jetRNA®+ 1 mL

Non-viral in vivo delivery reagents are the most powerful alternative to viral vectors for nucleic acid delivery. They offer substantial advantages in terms of reliability, safety and costs for nucleic-acid based therapies. Different quality grades of in vivo transfection reagents are available for proof concept studies, preclinical studies and clinical trials.